Skip to content

Concurrent training and telomere length in patients with myocardial infarction

clinical trial : The effect of concurrent training on telomere length in patients with myocardial infarction

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015112225188N1
Enrollment
20
Registered
2016-03-21
Start date
2014-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardial infarction. Acute transmural myocardial infarction of anterior wall Transmural infarction (acute)(of): anterior (wall) NOS anteroapical anterolateral anteroseptal

Interventions

Intervention 1: Intervention group: The training group will perform an 8-week exercise training protocol in three sessions per week. Intervention 2: Control group: The subjects in the control group wi
Rehabilitation
Intervention group: The training group will perform an 8-week exercise training protocol in three sessions per week.
Control group: The subjects in the control group will continue their daily lives during this period and wont carry out any exercise training.

Sponsors

Shahid Beheshti University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : passing four to eight weeks since occurrence of myocardial infarction; stable of patient's condition; quitting smoking and alcohol during the study. Exclusion criteria : unstable pectoral angina; decompensated heart failure; ventricular arrhythmia; orthopedic problems.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Telomere length. Timepoint: pre-post test. Method of measurement: telomere length- quantitative polymerase chain reaction (qPCR)- t/s.;Telomerase activity. Timepoint: pre-post test. Method of measurement: Telomerase activity- quantitative polymerase chain reaction (qPCR)- t/s.;Trf1. Timepoint: pre-post test. Method of measurement: trf1-Immunosorbent Assay (ELISA) -pg/ml.;Trf2. Timepoint: pre-post test. Method of measurement: trf1-Immunosorbent Assay (ELISA) -pg/ml.

Secondary

MeasureTime frame
-. Timepoint: -. Method of measurement: -.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehzad Saki

Shahid Beheshti University

b_saki@sbu.ac.ir; b.saki@ut.ac.ir+98 66 3252 0120

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026